Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

White blood cells and severe COVID-19: a Mendelian randomization study

View ORCID ProfileYitang Sun, View ORCID ProfileJingqi Zhou, View ORCID ProfileKaixiong Ye
doi: https://doi.org/10.1101/2020.10.14.20212993
Yitang Sun
1Department of Genetics, Franklin College of Arts and Sciences, University of Georgia, Athens, GA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Yitang Sun
Jingqi Zhou
1Department of Genetics, Franklin College of Arts and Sciences, University of Georgia, Athens, GA, USA
2School of Public Health, Shanghai Jiao Tong University School of Medicine, Shanghai, P.R. China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Jingqi Zhou
Kaixiong Ye
1Department of Genetics, Franklin College of Arts and Sciences, University of Georgia, Athens, GA, USA
3Institute of Bioinformatics, University of Georgia, Athens, GA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Kaixiong Ye
  • For correspondence: Kaixiong.Ye@uga.edu
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

Background The pandemic of coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has rapidly emerged to seriously threaten public health. We aimed to investigate whether white blood cell traits have potential causal effects on severe COVID-19 using Mendelian randomization (MR).

Methods To evaluate the causal associations between various white blood cell traits and severe COVID-19, we conducted a two-sample MR analysis with summary statistics from recent large genome-wide association studies.

Results Our MR results indicated potential causal associations of white blood cell count, myeloid white blood cell count, and granulocyte count with severe COVID-19, with odds ratios (OR) of 0.84 (95% CI: 0.72-0.98), 0.81 (95% CI: 0.70-0.94), and 0.84 (95% CI: 0.71-0.99), respectively. Increasing eosinophil percentage of white blood cells was associated with a higher risk of severe COVID-19 (OR: 1.22, 95% CI: 1.03-1.45).

Conclusions Our results suggest the potential causal effects of lower white blood cell count, lower myeloid white blood cell count, lower granulocyte count, and higher eosinophil percentage of white blood cells on an increased risk of severe COVID-19.

  • COVID-19
  • white blood cells
  • eosinophil
  • Mendelian randomization

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

KY is supported by the University of Georgia Research Foundation. Funding sources had no involvement in the conception, design, analysis, or presentation of this work.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The study does not analyze individual-level data.

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

All data generated or analyzed during this study are included in this published article and this supplementary information files.

  • List of abbreviations

    COVID-19
    coronavirus disease 2019
    SARS-CoV-2
    severe acute respiratory syndrome coronavirus 2
    MR
    Mendelian randomization
    GWAS
    genome-wide association studies
    SNPs
    single nucleotide polymorphisms
    LD
    linkage disequilibrium
    HGI
    Host Genetics Initiative
    IEU
    Integrative Epidemiology Unit
    IVW
    inverse variance-weighted
    WM
    weighted median
    MR-PRESSO
    Mendelian randomization pleiotropy residual sum and outlier
  • Copyright 
    The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.
    Back to top
    PreviousNext
    Posted October 18, 2020.
    Download PDF

    Supplementary Material

    Data/Code
    Email

    Thank you for your interest in spreading the word about medRxiv.

    NOTE: Your email address is requested solely to identify you as the sender of this article.

    Enter multiple addresses on separate lines or separate them with commas.
    White blood cells and severe COVID-19: a Mendelian randomization study
    (Your Name) has forwarded a page to you from medRxiv
    (Your Name) thought you would like to see this page from the medRxiv website.
    CAPTCHA
    This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
    Share
    White blood cells and severe COVID-19: a Mendelian randomization study
    Yitang Sun, Jingqi Zhou, Kaixiong Ye
    medRxiv 2020.10.14.20212993; doi: https://doi.org/10.1101/2020.10.14.20212993
    Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
    Citation Tools
    White blood cells and severe COVID-19: a Mendelian randomization study
    Yitang Sun, Jingqi Zhou, Kaixiong Ye
    medRxiv 2020.10.14.20212993; doi: https://doi.org/10.1101/2020.10.14.20212993

    Citation Manager Formats

    • BibTeX
    • Bookends
    • EasyBib
    • EndNote (tagged)
    • EndNote 8 (xml)
    • Medlars
    • Mendeley
    • Papers
    • RefWorks Tagged
    • Ref Manager
    • RIS
    • Zotero
    • Tweet Widget
    • Facebook Like
    • Google Plus One

    Subject Area

    • Epidemiology
    Subject Areas
    All Articles
    • Addiction Medicine (214)
    • Allergy and Immunology (495)
    • Anesthesia (106)
    • Cardiovascular Medicine (1090)
    • Dentistry and Oral Medicine (194)
    • Dermatology (141)
    • Emergency Medicine (274)
    • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (497)
    • Epidemiology (9746)
    • Forensic Medicine (5)
    • Gastroenterology (480)
    • Genetic and Genomic Medicine (2298)
    • Geriatric Medicine (221)
    • Health Economics (461)
    • Health Informatics (1548)
    • Health Policy (729)
    • Health Systems and Quality Improvement (600)
    • Hematology (236)
    • HIV/AIDS (500)
    • Infectious Diseases (except HIV/AIDS) (11618)
    • Intensive Care and Critical Care Medicine (615)
    • Medical Education (236)
    • Medical Ethics (67)
    • Nephrology (256)
    • Neurology (2136)
    • Nursing (133)
    • Nutrition (332)
    • Obstetrics and Gynecology (424)
    • Occupational and Environmental Health (516)
    • Oncology (1171)
    • Ophthalmology (363)
    • Orthopedics (128)
    • Otolaryngology (220)
    • Pain Medicine (144)
    • Palliative Medicine (50)
    • Pathology (308)
    • Pediatrics (692)
    • Pharmacology and Therapeutics (298)
    • Primary Care Research (265)
    • Psychiatry and Clinical Psychology (2168)
    • Public and Global Health (4640)
    • Radiology and Imaging (775)
    • Rehabilitation Medicine and Physical Therapy (450)
    • Respiratory Medicine (621)
    • Rheumatology (273)
    • Sexual and Reproductive Health (224)
    • Sports Medicine (208)
    • Surgery (250)
    • Toxicology (42)
    • Transplantation (120)
    • Urology (94)